Publication Abstract Display
Type: Published Abstract
Title: The utility and limitations of the HIV Dementia Scale.
Authors: Childers M, Ellis R, Deutsch R, Wolfson T, Grant I, and the HNRC Group
Year: 2002
Publication: Journal of the International Neuropsychological Society
Volume: 8 Issue: 2 Pages: 160
Abstract:Background: The HIV Dementia Scale (HDS) is a brief instrument designed to identify HIV-associated cognitive impairment. Objectives: Weassessed the scale’s utility by comparing HDS scores to global impairment ratings derived from a comprehensive neuropsychological (NP) test battery. Methods: Subjects were 164 HIV-seropositive men and 40 women enrolled in a prospective, longitudinal research study. Each completed the HDS and a comprehensive battery of standardized neuropsychological tests. Demographically-corrected NP test scores were used to assign a clinical global NP rating of impaired or not impaired, against which HDS scores were evaluated. In using an HDS cutoff score to identify impaired subjects, sensitivity was judged to be more important than specificity (i.e., a high proportion of HDS-impaired subjects would be impaired based on global NP ratings). For identifying unimpaired subjects, specificity was judged to be more important (i.e., a high proportion of HDS-unimpaired subjects would be unimpaired on global NP ratings). Results: HDS scores below 11 demonstrated 97% sensitivity and 32% specificity in identifying subjects with global NP impairment. HDS scores above 15 showed 61% sensitivity and 81% specificity in identifying those without NP impairment. Scores equal to and between 11 and 15 (44% of subjects) were indeterminate. HDS scores were significantly related to education and ethnicity. Conclusions: Given the caveats noted above, the HDS may be used to quickly confirm impairment status when the clinician reasonably suspects impairment or nonimpairment, and patients are unable to complete more extensive neuropsychological testing.

return to publications listing